Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & EMBASE  
     Home | Subscribe | Feedback  

[Download PDF
Year : 1994  |  Volume : 40  |  Issue : 4  |  Page : 197-201  

The role of initial 5-fluorouracil trabeculectomy in primary glaucoma.

YK Dastur, S Dasgupta, A Chitale, P Firke, J Patel, S Sethi, V Patwardhan 
 Dept of Ophthalmology, KEM Hospital, Parel, Bombay, Maharashtra.

Correspondence Address:
Y K Dastur
Dept of Ophthalmology, KEM Hospital, Parel, Bombay, Maharashtra.


Sixty-eight patients with primary glaucoma involving 68 eyes were divided into two groups: Group I eyes were subjected to trabeculectomy (n = 38) and Group II eyes underwent trabeculectomy followed by subconjunctival injections of 5-fluorouracil (35 mg) (n = 30). After one year follow-up, Group I eyes exhibited reduction of mean intra-ocular tension from 45.7 mm Hg (pre-operative) to 16 mm Hg; optic disc cupping remained unchanged and 24/38 eyes (63%) were found to have field defects (19/38 i.e. 50% had preoperative field defects.) Group II eyes showed a reduction of mean intra-ocular pressure from 47.3 mmHg to 9.3 mmHg after one year. Mean cup disc ratio was lowered from 0.50:1 to 0.46:1 and 17/30 eyes (57%) which had field defects initially continued to exhibit the same. Complications in Group I and II eyes were shallow anterior chamber [8/38 eyes (21%) from Group I and 8/30 eyes (26%) from Group II], posterior synechiae formation in 10/38 eyes (26%) and 8/30 eyes (26%) and cataract progression in 13/38 eyes (34%) and 12/30 eyes (40%) respectively; only Group II eyes had transient superficial keratitis in 9/30 eyes (30%) and thin blebs in 6/30 eyes (20%). The use of 5-fluorouracil after trabeculectomy for primary glaucoma resulted in lowering of intra-ocular pressure, eliminated the need for antiglaucoma medications post-operatively, reduced the galucomatous cup size, and prevented progression of field loss without having a significantly increased complication rate.

How to cite this article:
Dastur Y K, Dasgupta S, Chitale A, Firke P, Patel J, Sethi S, Patwardhan V. The role of initial 5-fluorouracil trabeculectomy in primary glaucoma. J Postgrad Med 1994;40:197-201

How to cite this URL:
Dastur Y K, Dasgupta S, Chitale A, Firke P, Patel J, Sethi S, Patwardhan V. The role of initial 5-fluorouracil trabeculectomy in primary glaucoma. J Postgrad Med [serial online] 1994 [cited 2020 Mar 28 ];40:197-201
Available from:

Full Text

  ::   IntroductionTop

Antifibrosis regime prevents scarring external to the scleral flap, which is the most important cause of filtration failure after trabeculectomy[1]. Scarring at the level of the conjunctiva  Tenon's capsule  episceral interface leads to increased intraocular pressure years after surgery[1]. It has been accepted over the years that use of 5fluorouracil (a pyrimidine analogue  an antimetabolite usually utilised for cancer therapy[2]) effectively inhibits fibroblastic proliferation in glaucomas with poor prognosis (viz aphakic glaucoma, neovascular glaucoma and inflammatory glaucomas)[2],[3],[4],[5],[6].

Of late, it has been shown that even patients of primary glaucoma operated for trabeculectomy usually have an intraocular pressure in the higher teens which effectively guards against visual field loss in only 50% patients[7],[8]. However, trabeculectomy with use of subconjunctival 5fluorouracil postoperatively lowers the intraocular pressure in cases of primary glaucoma to single digits[1],[7],[8],[9],[10],[11],[12],[13]. This lowered intraocular pressure prevents any further visual field loss. The present study was carried out to confirm whether the use of 5fluorouracil in eyes of primary glaucoma operated for trabeculectomy effectively lowers the intraocular pressure to a greater degree than after trabeculectomy alone. Further the effect of the lowered intraocular pressure on visual acuity, optic disc cupping, visual field loss and on the development of complications was studied.

  ::   MethodsTop

Sixty eight patients of primary glaucoma (with acute or chronic congestive glaucoma or chronic simple glaucoma) involving 68 eyes and who regularly attended prescribed followup for one year were selected for this prospective study. Patients with aphakic, neovascular, inflammatory glaucomas, having history of previously failed filtration surgery, receiving prolonged medical therapy for glaucoma and those who were treated elsewhere either medically or surgically were not included in this study.

Of the 68 eyes, 38 were treated with trabeculectomy alone and those were called 'Group I eyes' in this study, while 30 eyes treated with trabeculectomy and subconjunctival 5fluorouracil injection postoperatively were called as 'Group II eyes' in this study. The details regarding age and sex of patients belonging to these groups is presented in [Table:1].

In short, 'Group I eyes' belonged to 20 males and 18 females and 14/38 of patients were in the age group of 5165 years with the mean age of 51 years. 'Group II eyes' belonged to 17 males and 13 females and 14/30 of them were of age group 5165 years (mean 50 years).

The best corrected visual acuity was recorded for all the eyes in both the groups at the outset of the study. Primary glaucoma was diagnosed after complete ophthalmic examination including application tonometry, ophthalmoscopy, slit lamp examination, gonioscopy and kinetic perimetry. The patients subjected to trabeculectomy in both the groups were either the cases with acute glaucomatous attack or with intraocular pressure above 25 mm/Hg, optic disc cupping and with or without visual field changes. Secondary glaucoma was ruled out by slit lamp evidences of flare, KP's, rubeosis or ophthalmoscopic evidences of optic disc neovascularization.

Blood pressure, blood sugar, sac patency were checked in all the patients prior to trabeculectomy. Operation was carded out after medical control of glaucoma by oral acetazolamide and topical 2% pilocarpine or 0.25% timolol or 0.5 % betaxolol. Watson's modification of trabeculectomy consisted of limbal based conjunctival and square shaped limbal based scleral flap. After trabecular tissue excision iridectomy was done in all the patients. Following operation all received oral antibiotics for three days, along with 1 % chloramphenicol eye ointment at night and 0.03% flurbiproper eye drops three times daily. After discharge, treatment at night with 1% chloramphenicol eye ointment was continued for 3 weeks while 0.03% flurbiprofen eye drops were continued thrice daily for 3 months. In addition, 'Group II eyes' were subjected to postoperative subconjunctival injections of 5fluorouracil from 2nd postoperative day. 5Fluorouracil (5 mg/0.1 ml) was injected subconjunctivally thrice (on alternate day) in the first week and again thrice in the second postoperative week. Only in patients below the age of 40 years and in those with thick Tenon's capsule another three subconjunctival injections of 5fluorouracil were given in the third postoperative week. Thus 20 patients received 6 injections (30 mg of 5 fluorouracil) and 10 received 9 injections (45 mg of 5 fluorouracil). The mean dose of 5 fluorouracil administered was 35 mg.

These 5fluorouracil subconjunctival injections were given after instillation of 4% lignocaine eye drops in the conjunctival sac. A cotton tipped wooden applicator soaked in 4% lignocaine was placed on the bulbar conjunctiva at the site of injection for 3060 sec. A patient was instructed to direct his gaze away from the applicator so that the cornea was not abraded. Using a 2 ml syringe, 0.2 mi of 5fluorouracil (50 mg/ml) was withdrawn, 26gauge needle was attached and all the air bubbles in the needle were removed. At the chosen site 1800 away from the filtration bleb 0.1 ml was injected. Any reflux of 5fluorouracil from the needle hole in the bulbar conjunctiva was prevented by pressing a dry cottontipped wooden applicator at the site of injection for 1 minute. Chloramphenicol eye ointment (1%) was applied to protect the cornea from further leakage of 5fluorouracil. Even in patients with superficial punctate keratitis (nonconfluent type) and shallow anterior chamber, the 5flurouracil conjunctival injections were continued as usual.

'Group I eyes' were followed up at weekly intervals after discharge for 1 month, 2 weekly intervals for next 2 months and at monthly intervals for 1 year postoperatively. 'Group II eyes' treated with 69 subconjunctival 5fluorouracil injections on outpatient basis (i.e. 1st 3 weeks), were followed up at 2 weekly intervals for the next 2 months and at monthly intervals for 1 year postoperatively.

During followup the patients in both the groups were examined for best corrected visual acuity, intraocular pressure, cupdisc ratio and kinetic perimetry at 3 months and 1 year postoperatively. The patients with postoperative tension more than 20 mmHg were administered 0.5% betaxolol eye drops twice daily. Those with advanced cataracts underwent cataract extraction by extracapsular technique with posterior chamber implant using an upper quadrant corneal incision.

  ::   ResultsTop

In 'Group I eyes' 15/38 (40%) eyes had acute or chronic congestive glaucoma and 23/38 eyes (60%) had chronic simple glaucoma. Preoperatively 9138 eyes (24%) had 6/12 or better vision with mean preoperative tension of 45.7 mmHg [Table:2], mean cup disc ratio of 0.42:1 [Table:3] and 19/38 eyes (50%) had glaucomatous visual field defects on kinetic perimetry.

After 1 year of conventional trabeculectomy, these 38 'Group I eyes' showed that 8/38 eyes (21%) had 6/12 or better vision, with mean tension of 16 mmHg [Table:2], mean cup disc ratio of 0.41:1 [Table:3] and glaucomatous visual field defects in 24/38 eyes (63%). [Table:2] and [Table:3]. Further 'Group I eyes' showed complications such as shallow anterior chamber (8/ 38 eyes; 21 %) and posterior synechia (10/38 eyes; 26%). Though 7/38 (18%) eyes had shown presence of cataract preoperatively, 1 year after trabeculectomy 13/38 eyes (34%) had cataract [Table:4]. During this period of one year followup, 5 of these 13 cataracts had to be operated by extracapsular technique with posterior chamber lens implant. All these 5 operated cataracts had no operative complication and had visual recovery of 2 to 3 lines on Snellen's visual acuity chart.

In 'Group II eyes' 10/30 eyes (33%) had acute or chronic congestive glaucoma and 20/30 (67%) had chronic simple glaucoma. Preoperatively 7/30 eyes (23%) had 6/12 or better vision with mean preoperative tension of 47.3 mmHg [Table:2], mean cup disc ratio 0.50 A [Table:3] and 17/30 eyes (57%) had glaucomatous visual field defects. After 1 year of trabeculectomy and mean dose of 35 mg of subconjunctival postoperative 5fluorouracil, 8/30 eyes (26%) had 6/12 or better vision with a mean posttreatment tension of 9.3 mm Hg [Table:2], mean cup disc ratio of 0.46:1 [Table:3] and glaucomatous visual field defects in 17/30 eyes (57%), These 'Group II eyes' showed complications such as shallow anterior chamber in 8/30 eyes (26%); 9/30 eyes (30%) had superficial punctate keratitis (nonconfluent type), 6/30 eyes (20%) had thin filtration Blebs, 8/30 eyes (26%) had posterior synechia. While 7/30 (23%) had cataracts preoperatively, after 1 year of operation 12/30 (40%) had cataracts [Table:4].

Seven of these 12 cases were operated by extracapsular technique with posterior chamber lens implant. These 7 operated cataracts had no operative complications and had visual recovery of 2 to 3 lines on Snellen's visual acuity chart.

  ::   DiscussionTop

Antifibrosis regimen is presently combined with trabeculectomy for aphakic, neovascular, inflammatory glaucomas which have poor prognosis and for patients in whom filtration surgery has tailed[2],[3],[4],[5],[6].

Liebmann, et al[1], Wilson[7],[8],[9],[10] and Palmer[12] have stated that even for cases of primary glaucoma antifibrosis regimen should be used adjunctively with the trabeculectomy. Antifibrosis regimen consists of administration of antimetabolite drug such as 5fluorouracil, which is a inhibitor of DNA synthesis inhibitor and hence prevents fibroblastic proliferation at the site of the filtration bleb. The other drug used in the antifibrosis regimen is mitomycin[11],[12] which also inhibits DNA synthesis and is applied once during trabeculectomy to the operated site in the concentration of 0.2 mg/ml. Mitomycin is 100 times more potent in its antifibroblastic action than 5fluorouracil. In this study we have evaluated the role of 5fluorouracil as an adjunct to trabeculectomy for primary glaucoma.

One year after the conventional trabeculectomy there was a 65% reduction of intraocular pressure to a mean value of 16 mmHg, while subconjunctival injections of 5fluorouracil following trabeculectomy led to 80% reduction in intraocular pressure (9.3 mm Hg). Our findings thus confirms the reports in the literature[6],[9],[11],[13],[14].

While conventional trabeculectomy did not result in a reduction in the mean cup disc ratio, trabeculectomy followed by 5fluorouracil injections effectively reduced the size of the galucomatous cup. Similar results have been reported by others[15],[16].

One year after the conventional trabeculectomy, 13% of the eyes had progressive field loss but none of the eyes treated with trabeculectomy and 5fluorouracil injections had progressive visual field loss. This was also observed by other workers[7],[17],[18].

Trabeculectomy with adjunctive 5fluorouracil did not result in a substantial loss of vision in our study in comparison with eyes subjected to trabeculectomy alone. However, other workers[7],[8],[9] have stated that the patients treated with trabeculectomy and 5fluorouracil have low tension and consequently have fluctuating or seriously blurred vision.

This study shows that the complication incidence is similar in both Group I and II eyes. However, superficial punctate keratitis (30%) and thin filtration blebs (20%) occurred only in eyes treated with adjunctive 5fluorouracil injections. These complications have been reported in other studies as well[3],[4],[9],[10].

Hence, this study confirms that the postoperative use of 5fluorouracil is beneficial as it causes a greater lowering of intraocular pressure which consequently reduces the glaucomatous cup size, prevents progression of visual field loss and eliminates the need for postoperative anti-glaucoma medications. Wolner[7] has reported a 3% incidence of bleb related delayed endophthalmitis for trabeculectomies done from above postoperatively and treatment with 5fluorouracil injections and 9.4% when performed from below. Other workers[3],[4],[5] have reported a delayed endophthalmitis due to thin and leaking filtration belbs in 1% of cases. In our study with one year followup none of the 30 'Group II eyes' have developed endophthalmitis, however 6/30 eyes (20%) had thin filtration blebs. Perhaps a long term study with a followup of over 5 to 10 years is necessary to determine whether these eyes subjected to trabeculectomy with adjunctive 5Fluorouracil have a higher incidence of bleb related endophthalmitis compared with those subjected to trabeculectomy alone.


1 Liebmann JM, Retch R, Marmor M, Nunez J, Wolner B. Initial 5fluorouracil trabeculectomy in uncomplicated glaucoma. Ophthalmology 1991; 98:10361041.
2Sood NN, Kumar H, Agarwal HC, Sihota R. Role of 5-fluorouracil in the management of failed glaucoma surgery. Indian J Ophthalmol 1990; 38:1719.
3Heuer DK, Parrish RK, Gressel MG. 5  fluorouracil and glaucoma filtering surgery III intermediate followup of a pilot study. Ophthalmology 1986; 93:15371546.
4Rockwood EJ, Parrish RK, Heuer DK. Glaucoma filtering surgery with 5fluorouracil. Ophthalmology 1987; 94:1071108.
5Ruderman JM, Welch DB, Smith MF, Shoch DE. A randomized study of 5fluorouracii and filtration surgery. Am J Ophthalmol 1987; 104:218224.
6The fluorouracil filtering surgery study group. Flourouracil filtering surgery study one year followup. Am J Ophthalmol 1989; 108:625635.
7Wilson RP. Glaucoma: introduction In: Laibson PR, editor, Year Book of Ophthalmology: 991, Chicago: Mosby Year Book Inc; 1991, pp 5354.
8Wilson RP. Glaucoma. In: Laibson PR, editor. Year Book of Ophthalmology, 1992. Chicago: Mosby Year Book Inc; 1992, pp 6769.
9Wilson RP, Glaucoma care. In: Laibson PR, editor. Year Book of Ophthalmology, 1990. Chicago: Mosby Year Book Inc; l990, pp 4849.
10Wilson RP. Glaucoma care  1988. In: Laibson PR, editor. Year Book of Ophthalmology, 1989. Chicago: Mosby Year Book Inc, 1989, pp 48.
11Kitazawa Y, Kawase K, Matsushita H, Minobe M. Trabeculectomy with mitomycin: comparative study with fluorouracil. Arch of Ophthalmol 1991; 109:16931698.
12Palmer SS. Mitomycin as adjunct chemotherapy with trabeculectomy. Ophthalmology 1991; 98:317321.
13Khan AM, Jilani FA, Das S. A comparative study between with and without subconjunctival 5fluorouracil injection after trabeculectomy in primary glaucoma. Proc All India Ophthal Soc 1992; 370371.
14Jilani FA, Das S. Study of complications following subconjunctival injection of 5fluorouracil after trabeculectomy procedure. Proc All India Ophthamol Soc 1992; 367369.
15Katz U, Spaeth GL, Cantor LB. Reversible optic disc cupping and visual field improvement in adults with glaucoma. Am J Ophthalmol 1989; 107:485492.
16Parrow KA, Shim DH, Tsai CS. Intraocular pressure dependent dynamic changes of optic disc cupping in adult glaucoma patients. Ophthalmology 1992; 99:3640.
17Roth SM, Spaeth GL, Satarita RJ. The effects of postoperative corticosteroids on trabeculectomy and the clinical course of glaucoma. Five year followup study. Ophthal Surg 1991; 22:724729.
18Tsai CS, Shin DH, Wan JY. Visual field global indices in patients with reversal of glaucomatous cupping after intraocular pressure reduction. Ophthalmology 1991; 98:14121418.

Saturday, March 28, 2020
 Site Map | Home | Contact Us | Feedback | Copyright  and disclaimer